Poor Survival in Multiple Myeloma Patients Linked to Genetic Variation

As part of a multi-institutional effort, researchers with Huntsman Cancer Institute at the University of Utah have found that multiple myeloma patients with a genetic variation in the gene FOPNL die on average one to three years sooner than patients without it. The finding was identified with a genetic mapping technique, genome wide association studies (GWAS), and verified in patient populations from North America and Europe. This was the first study to survey the entire human genome for genetic...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news